Closure of Trading Window
The trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designated Employees of the Company from the trading hours on 01.02.2018 till 15.02.2018 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company for declaration of un-audited financial results for the quarter ended 31.12.2017. Intimation Of Board Meeting To Be Held On 13.02.2018
Intimation of Board meeting to be held on 13.02.2018 Shareholding for the Period Ended December 31, 2017
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended 31.12.2017
statement of investor complaints for the quarter ended 31.12.2017 Financial Results For The Quarter Ended 30.09.2017
Financial results for the quarter ended 30.09.2017 Board Meeting Postponed
Sub: Postponement of Board Meeting Ref: Scrip Code 538965 With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of M/s. Concord Drugs Limited which was scheduled to be held on Wednesday, 13.12.2017 at 10:00 a.m. at the registered office of the company at Survey No.249, Brahmanapally Village, Hayatnagar Mandal-501511,Telangana has been postponed to Thursday, 14.12.2017 at 4.30 p.m. to consider the following:... Shareholding for the Period Ended November 15, 2017
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended November 15, 2017. For more details, kindly Click here